Pediatr. praxi. 2012;13(1):12-15

Komplex metabolic changes in children with obesity

MUDr.Zlatko Marinov1, MUDr.Dalibor Pastucha, Ph.D., MBA2
1 Dětská obezitologická ambulance, Dětská poliklinika FN Motol Praha
2 Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace FN Olomouc

According to current statistics, there are at an average child‘s general practice about seventy children registered with obesity, including

fifty children indicated for long-term treatment of obesity due to medical indications and fifteen children are intended for targeted

modifications in their diet. Currently, we are exposed to pandemic common obesity, which is a chronic metabolic disease with societal

consequences. Common obesity mainly reflects an early onset of cardio-metabolic risk, but the clinical picture of complications of

childhood obesity is broader and includes not only the risk of life-limitation, but also respiratory, gastrointestinal, neurological, orthopaedic

and endocrine complications along with serious psychosocial problems. The effects caused by childhood obesity are reversible

initially, and early identification and treatment is a major clinical challenge in preventing the development of serious metabolic, organ,

psychological and societal complications.

Keywords: obesity in children, kardio-metabolic risk, metabolic syndrom, liver steatosis, obstructive sleep apnea syndrom

Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marinov Z, Pastucha D. Komplex metabolic changes in children with obesity. Pediatr. praxi. 2012;13(1):12-15.
Download citation

References

  1. Pastucha D, Hyjánek J, Horáková D. Hypertenze dětského věku a její vztah k inzulínové rezistenci. Pediatr. praxi 2007; 8: 237-239.
  2. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol. 2009, 28; 15(48): 6017-6022. Go to original source... Go to PubMed...
  3. Kohler MJ. Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med. 2009, 15; 5(6): 506-511. Go to original source...
  4. Horakova D, Stejskal D, Pastucha D, et al. Potential markers of insuline resistance in healthy vs obese and overweight subjects. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(3): 245-250. Go to original source... Go to PubMed...
  5. Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes. 2006; 1(1): 33-41. Go to original source... Go to PubMed...
  6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 24; 348(17): 1625-1638. Go to original source... Go to PubMed...
  7. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am j Clin Nutr 2006; 83: 1237-1247. Go to original source... Go to PubMed...
  8. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007; 8(5): 299-306. Go to original source... Go to PubMed...
  9. Simmons RK, Alberti KG, Gale EA, Colagiuri S, et al. The metabolic syndrome: useful concept or clinical tool? Diabetologia 2010; 53(4): 600-605. Go to original source... Go to PubMed...
  10. Pastucha D, Talafa V, Malincikova J, et al. Obesity, hypertension and insulin resistance in childhood - a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(1): 77-82. Go to original source... Go to PubMed...
  11. Pastucha D, Malinčíková J, Číhalík Č, et al. Obesity, hypertension and insulin resistance in childhood. Acta Medica Martinina 2008; 8(1): 17-22.
  12. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents. Circulation 2009; 119(4): 628-647. Go to original source... Go to PubMed...
  13. Marinov Z, Čepová J. Metabolické parametry pacientů dětské obezitologické ambulance. ČS. Pediatrie 2010; 2: 72-78.
  14. Vitáriušová E, Košťálová Ľ, Pribilincová Z, et al. Výskyt metabolického syndrómu a jeho komponentov u obéznych detí. ČS. Pediatrie 2010; 2: 55-61.
  15. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010; 26: 5-11. Go to original source... Go to PubMed...
  16. Musso G, Gambino R, Cassader M. Obesity, Diabetes, and Gut Microbiota. Diabetes Care 2010; 33: 2277-2284. Go to original source... Go to PubMed...
  17. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003, 8; 289(2): 187-193. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.